TGA criticised over lack of safety warnings

Press/Media: Expert Comment

Description

Article in NewsGP about medication warnings from the TGA and inbuilt GP software.

Subject

Questions have been raised over the way Australia’s therapeutic regulator is informing doctors and patients about potentially dangerous drugs.

Period7 May 2019

Media contributions

1

Media contributions

  • TitleTGA criticised over lack of safety warnings
    Degree of recognitionNational
    Media name/outletNews G{
    Media typeWeb
    CountryAustralia
    Date7/05/19
    DescriptionQuestions have been raised over the way Australia’s therapeutic regulator is informing doctors and patients about potentially dangerous drugs.
    The criticism stems from a comparative analysis of how often medicines regulators in four countries – Australia, Canada the US and the UK – issued safety advisories about the same potential health risks.

    The study, which examined notifications issued between 2007 and 2016, revealed major discrepancies in the way potential safety warnings were disseminated in each country, with Australia seemingly lagging in many areas.

    ‘The Therapeutic Goods Administration [TGA] issued safety warnings on less than 30% of the issues identified by regulators in Canada, the US and the UK,’
    Producer/AuthorMatt Woodley
    PersonsMark Morgan